{"result": "(\"entity\"<|>DRA. ROSA BURGOS PELÁEZ<|>PERSON<|>Dr. Rosa Burgos Peláez is a medical professional involved in the study of lipids and their impact on health.)\n##\n(\"entity\"<|>DRA. M.ª NURIA VIRGILI CASAS<|>PERSON<|>Dr. M.ª Nuria Virgili Casas is a medical professional who collaborates on topics related to lipids and health.)\n##\n(\"entity\"<|>DRES. MIGUEL Á. RUBIO<|>PERSON<|>Dr. Miguel Á. Rubio is a medical professional focusing on the influence of diet on hyperlipidemia and cardiovascular risk.)\n##\n(\"entity\"<|>CARMEN MORENO<|>PERSON<|>Carmen Moreno is a medical professional who works on the influence of diet on hyperlipidemia and cardiovascular risk.)\n##\n(\"entity\"<|>ADRENOLEUCODISTROFIA<|>EVENT<|>Adrenoleukodystrophy is a genetic disorder affecting lipid metabolism, requiring controlled diets in fatty acids.)\n##\n(\"entity\"<|>QUILOTÓRAX<|>EVENT<|>Chylothorax is a condition involving lymphatic fluid accumulation in the pleural cavity, often related to lipid metabolism disorders.)\n##\n(\"entity\"<|>ASCITIS QUILOSA<|>EVENT<|>Chylous ascites is a condition characterized by the accumulation of lymphatic fluid in the abdominal cavity, associated with lipid metabolism issues.)\n##\n(\"relationship\"<|>DRA. ROSA BURGOS PELÁEZ<|>ADRENOLEUCODISTROFIA<|>Dr. Rosa Burgos Peláez is involved in the study and management of adrenoleukodystrophy, focusing on dietary control of fatty acids.<|>7)\n##\n(\"relationship\"<|>DRA. M.ª NURIA VIRGILI CASAS<|>ADRENOLEUCODISTROFIA<|>Dr. M.ª Nuria Virgili Casas collaborates on research related to adrenoleukodystrophy and dietary management.<|>7)\n##\n(\"relationship\"<|>DRES. MIGUEL Á. RUBIO<|>QUILOTÓRAX<|>Dr. Miguel Á. Rubio studies the influence of diet on conditions like chylothorax, which is related to lipid metabolism.<|>6)\n##\n(\"relationship\"<|>CARMEN MORENO<|>QUILOTÓRAX<|>Carmen Moreno works on the dietary aspects affecting chylothorax, linking it to lipid metabolism disorders.<|>6)\n##\n(\"relationship\"<|>DRA. ROSA BURGOS PELÁEZ<|>QUILOTÓRAX<|>Dr. Rosa Burgos Peláez is involved in research related to chylothorax and its dietary implications.<|>5)\n##\n(\"relationship\"<|>DRA. M.ª NURIA VIRGILI CASAS<|>QUILOTÓRAX<|>Dr. M.ª Nuria Virgili Casas collaborates on studies regarding chylothorax and its management through diet.<|>5)\n##\n(\"relationship\"<|>DRES. MIGUEL Á. RUBIO<|>ASCITIS QUILOSA<|>Dr. Miguel Á. Rubio's research includes the dietary management of chylous ascites, linking it to lipid metabolism.<|>6)\n##\n(\"relationship\"<|>CARMEN MORENO<|>ASCITIS QUILOSA<|>Carmen Moreno focuses on the dietary factors influencing chylous ascites, which is related to lipid metabolism disorders.<|>6)\n##\n(\"relationship\"<|>DRA. ROSA BURGOS PELÁEZ<|>ASCITIS QUILOSA<|>Dr. Rosa Burgos Peláez is involved in the study of chylous ascites and its dietary management.<|>5)\n##\n(\"relationship\"<|>DRA. M.ª NURIA VIRGILI CASAS<|>ASCITIS QUILOSA<|>Dr. M.ª Nuria Virgili Casas collaborates on research regarding chylous ascites and dietary control.<|>5)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: 0.Consultado          7/1/2017.      www.omim.                   2010; 17(1): 36–42. Disponible en: http://www.\n     org/entry/36200                                                           ncbi.nlm.nih.gov/pmc/articles/PMC3099242/\n23.  Picker JD, Levy HL. Homocystinuria caused by cys-                   33.   Banka S, Newman W. A clinical and molecular re-\n     tathionine    beta-synthase       deficiency.    Gene     Re-             view of ubiquitous glucose-6-phosphatase defi-\n     views.    Actualizado       13/11/2014.        Consultado                 ciency caused by G6PC3 mutations.Orphanet J\n     7/1/2017.      https://www.ncbi.nlm.nih.gov/books/                        RareDis. 2013; 8: 84. Disponible en: http://www.\n     NBK1116                                                                   ncbi.nlm.nih.gov/pmc/articles/PMC3718741\n24.  Schwab U, Törrönen A, Toppinen L, Alfthan G,                        34.   Asociación Española de Enfermos de Glucogeno-\n     Saarinen M, Aro A, et al. Betaine supplementation                         sis,  (AEEG).     Glucogenosis.org.        Disponible     en:\n     decreases    plasma     homocysteine       concentrations                 http://www.glucogenosis.org [updated 2016 Feb\n     but does not affect body weight, body composi-                            19]\n     tion, or resting energy expenditure in human sub-                   35.   Özen H. Glycogen storage disease: New perspecti-\n     jects. Am J Clin Nutr 2002; 76: 961-967.                                  ves. World J Gastroenterol. 2007; 13(18): 2541–\n25.  National Urea Cycle Disorders Foundation. What is                         2553.    Disponible     en:   http://www.ncbi.nlm.nih.\n     a Urea Cycle Disorder.Consultado 7/1/2017. www.                           gov/pmc/articles/PMC4146814/\n     nucdf.org/ucd.htm                                                   36.   Correia CE, et al. Use of modified cornstarch the-\n26.  Lichter-Konecki U, Cladovic L, Morizono H, Simp-                          rapy to extend fasting in glycogen storage disease\n     son K. Urea cycle disorders overview. Gene Re-                            types la and Ib. American Journal of Clinical Nutri-\n     views.     Actualizado       14/4/2016.        Consultado                 tion. 2008; 88 (5): 1272- 1276. Disponible en:\n     7/1/2017.      https://www.ncbi.nlm.nih.gov/books/                        http://ajcn.nutrition.org/content/88/5/1272.full\n     NBK11217                                                            37.   Maritz CM, Cousins A, Murphy E. Reduction in in-\n27.  Hamosh A. Ornithine transcarbamylase deficiency,                          sulin response in a patientwith GSD1 using a new\n     hyperammoniemia due to. OMIM© – Online Men-                               modifiedstarch: Case report.         Molecular Genetics\n     delian Inheritance in Man©.Actualizado 1/7/2015.                          and Metabolism 2009; 98: 39.\n     Consultado         7/1/2017.         www.omim.org/en-               38.   Humphrey MS. The use of Glycosade™ toextend-\n     try/311250#                                                               fastingtolerance and improve oral intake in GS-\n28.  Bachmann C. Long-term outcome of patients with                            D1b. Molecular Genetics and           Metabolism 2009;\n     urea cycle disorders and the question of neonatal                         98:116.\n     screening.    Eur   J  Pediatr   2003;    162    (Suppl    1)       39.   Kim S, Bae Y. Cell death and stress signaling in\n     S29-S33.                                                                  glycogen     storage     disease    type    I.  Mol    Cells.\n29.  Glycogen storage disease Ia; GSD1A. OMIM© –                               2009;28(3):139-48. Disponible en: http://www.\n     Online Mendelian Inheritance in Man©.Actualiza-                           ncbi.nlm.nih.gov/pubmed/19756389\n---\nNO_CONTENT_HERE\n---\nBLOQUE:\nLÍPIDOS\n(Dra. Rosa Burgos Peláez y\nDra. M.ª Nuria Virgili Casas)\nTEMA 19.     Influencia de la dieta en el control de la hiperlipemia\n             y el riesgo cardiovascular.\n             Dres. Miguel Á. Rubio y Carmen Moreno\nTEMA 20.     Trastornos congénitos del metabolismo de los lípidos:\n             Adrenoleucodistrofia. Dieta controlada en ácidos grasos.\n             Dres. Rosa Burgos Peláez, Mireia Guerrero Gual, Guillermo Cárdenas Lagranja\n             y Hegoi Segurola Gurrutxaga\nTEMA 21.     Quilotórax y ascitis quilosa.\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}